Spots Global Cancer Trial Database for antithymocyte globulin
Every month we try and update this database with for antithymocyte globulin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy | NCT02487069 | Acute Leukemia Chronic Myeloid... Myelodysplastic... | HSCT from MSD HSCT from MUD HSCT from HRD Cyclosporin A Methotrexate Antithymocyte g... Mycophenolate m... | 18 Years - 60 Years | Nanfang Hospital, Southern Medical University | |
| Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT01471444 | Disorder Relate... Leukemia Transplantation... | Fludarabine Clofarabine Busulfan Thymoglobulin Stem Cell Infus... Tacrolimus Methotrexate | 3 Years - 70 Years | M.D. Anderson Cancer Center | |
| Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients | NCT00499889 | Leukemia | Imatinib Mesyla... Fludarabine (Fl... Busulfan Antithymocyte G... Tacrolimus Methotrexate Donor lymphocyt... Stem Cell Trans... | - 70 Years | M.D. Anderson Cancer Center | |
| Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome | NCT00475020 | Myelofibrosis | Busulfan Fludarabine Thymoglobulin (... | - 75 Years | M.D. Anderson Cancer Center | |
| Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation | NCT05634915 | Hematopoietic S... Acute Leukemia | Individual ATG ATG | 16 Years - 60 Years | The First Affiliated Hospital of Soochow University | |
| Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT01471444 | Disorder Relate... Leukemia Transplantation... | Fludarabine Clofarabine Busulfan Thymoglobulin Stem Cell Infus... Tacrolimus Methotrexate | 3 Years - 70 Years | M.D. Anderson Cancer Center | |
| Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus | NCT00133367 | Multiple Myelom... Non-Hodgkin's L... Hodgkin's Disea... Myelogenous Leu... Lymphoblastic L... | Tacrolimus Sirolimus G-CSF Antithymocyte g... Thymoglobulin Fludarabine Melphalan | 18 Years - 65 Years | Massachusetts General Hospital | |
| Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC) | NCT02702960 | Fibrolamellar H... Hepatocellular ... Hepatocellular ... | living related ... Total body irra... Bone marrow tra... Cyclophosphamid... Mesna Filgrastim Tacrolimus mycophenolate m... Prednisone Antithymocyte g... fludarabine | 16 Years - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin | NCT00822770 | Stem Cell Trans... Leukemia | Plerixafor Filgrastim Fludarabine Busulfan Allogeneic bloo... ATG (Thymoglobu... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin | NCT00822770 | Stem Cell Trans... Leukemia | Plerixafor Filgrastim Fludarabine Busulfan Allogeneic bloo... ATG (Thymoglobu... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies. | NCT00890500 | Hematologic Mal... Allogeneic Stem... | Fludarabine Melphalan Antithymocyte G... Sirolimus Tacrolimus | 18 Years - 65 Years | Fate Therapeutics | |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies | NCT00857389 | Stem Cell Trans... Leukemia Lymphoma | Thiotepa Clofarabine Busulfan Allogeneic Stem... Thymoglobulin (... G-CSF (Filgrast... Tacrolimus Methotrexate Cyclophosphamid... Mesna | - 60 Years | M.D. Anderson Cancer Center | |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies | NCT01471067 | Blood And Marro... Leukemia Lymphoma Transplantation... Transplantation... | Melphalan Fludarabine Mycophenolate m... Tacrolimus Cord Blood Infu... Rituximab ATG Busulfan Clofarabine Total Body Irra... | 1 Year - 80 Years | M.D. Anderson Cancer Center | |
| Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy | NCT02487069 | Acute Leukemia Chronic Myeloid... Myelodysplastic... | HSCT from MSD HSCT from MUD HSCT from HRD Cyclosporin A Methotrexate Antithymocyte g... Mycophenolate m... | 18 Years - 60 Years | Nanfang Hospital, Southern Medical University | |
| Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT00402558 | Myelodysplastic... Leukemia | Thymoglobulin Busulfan Fludarabine Alloreactive NK... G-CSF Tacrolimus Methotrexate Interleukin-2 | - 70 Years | M.D. Anderson Cancer Center | |
| A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome | NCT00001839 | Hematologic Dis... Myelodysplastic... | Antithymocyte g... Cyclosporine | - | National Institutes of Health Clinical Center (CC) | |
| A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome | NCT00001839 | Hematologic Dis... Myelodysplastic... | Antithymocyte g... Cyclosporine | - | National Institutes of Health Clinical Center (CC) | |
| A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome | NCT00001839 | Hematologic Dis... Myelodysplastic... | Antithymocyte g... Cyclosporine | - | National Institutes of Health Clinical Center (CC) | |
| Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome | NCT00488436 | Myelodysplastic... | Antithymocyte g... Cyclosporine | - | PETHEMA Foundation | |
| Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT00402558 | Myelodysplastic... Leukemia | Thymoglobulin Busulfan Fludarabine Alloreactive NK... G-CSF Tacrolimus Methotrexate Interleukin-2 | - 70 Years | M.D. Anderson Cancer Center | |
| Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor | NCT00523809 | Breast Cancer Ovarian Cancer | Bevacizumab Allogeneic Hema... Fludarabine Melphalan Thymoglobulin | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy | NCT02487069 | Acute Leukemia Chronic Myeloid... Myelodysplastic... | HSCT from MSD HSCT from MUD HSCT from HRD Cyclosporin A Methotrexate Antithymocyte g... Mycophenolate m... | 18 Years - 60 Years | Nanfang Hospital, Southern Medical University | |
| Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia | NCT00005937 | Myelodysplastic... | Antithymocyte g... Cyclosporine | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells | NCT01362452 | Leukemia Lymphoma | T-Cell Infusion Cord Blood Infu... | 1 Year - 75 Years | M.D. Anderson Cancer Center | |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies | NCT01471067 | Blood And Marro... Leukemia Lymphoma Transplantation... Transplantation... | Melphalan Fludarabine Mycophenolate m... Tacrolimus Cord Blood Infu... Rituximab ATG Busulfan Clofarabine Total Body Irra... | 1 Year - 80 Years | M.D. Anderson Cancer Center | |
| Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome | NCT00488436 | Myelodysplastic... | Antithymocyte g... Cyclosporine | - | PETHEMA Foundation | |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies | NCT00857389 | Stem Cell Trans... Leukemia Lymphoma | Thiotepa Clofarabine Busulfan Allogeneic Stem... Thymoglobulin (... G-CSF (Filgrast... Tacrolimus Methotrexate Cyclophosphamid... Mesna | - 60 Years | M.D. Anderson Cancer Center | |
| Busulfan and Cyclophosphamide Followed By ALLO BMT | NCT01685411 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... | Allopurinol Keppra Busulfan Cyclophosphamid... Tacrolimus Mycophenolate m... Allogeneic hema... Filgrastim antithymocyte g... | - 44 Years | Masonic Cancer Center, University of Minnesota | |
| Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease | NCT00385788 | Hodgkin's Disea... | Gemcitabine Fludarabine Melphalan Antithymocyte G... Allogeneic Stem... Tacrolimus Filgrastim (G-C... Methotrexate | - 65 Years | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
